Urology Xagena

Xagena Mappa
Medical Meeting

Search results for "Cabozantinib"

Treatment with Cabozantinib ( Cometriq ) has reduced the rate of disease progression or death by 42% compared to Everolimus ( Afinitor ) in METEOR, a phase III trial comparing Cabozantinib to Everolim ...

Renal cell carcinoma ( RCC ) accounts for approximately 330,000 cases diagnosed each year and 140,000 deaths worldwide. Most cases are localized; however, one-third of patients present with an advanc ...

Cabozantinib ( Cabometyx ) has shown robust clinical activity in advanced clear cell renal cell carcinoma ( RCC ). Non-clear cell renal cell carcinoma ( nccRCC ), a heterogeneous mix of diseases, ha ...